Blog
RSS FeedPosted by Michael Wonder on 08 Jun 2018
Ombudsman report on Bupa highlights regional divide
8 June 2018 - The Ombudsman’s investigation of Bupa policy changes has highlighted the regional divide in health insurance, potentially ...
Posted by Michael Wonder on 08 Jun 2018
Decision to fund denosumab for osteoporosis
8 June 2018 - PHARMAC is pleased to announce a decision to fund denosumab (Prolia) for the treatment of severe, ...
Posted by Michael Wonder on 07 Jun 2018
Pfizer wins appeal against £84m UK fine over epilepsy drug price
7 June 2018 - Tribunal finds competition watchdog was wrong in its market dominance conclusions. ...
Posted by Michael Wonder on 07 Jun 2018
UK health spends lags behind EU peers
7 June 2018 - The amount the UK spends on health falls well behind that invested by European peers such ...
Posted by Michael Wonder on 07 Jun 2018
Takeda pioneers NICE’s new service for economic model review
7 June 2018 - NICE Scientific Advice (NSA) launched a new health economic model review service, PRIMA, in December 2017 and ...
Posted by Michael Wonder on 07 Jun 2018
Rapid rise in anti-HIV PrEP pills linked to drop in condom use
7 June 2018 - PrEP availability may play a part in men’s complacency about the chances of becoming infected, study suggests. ...
Posted by Michael Wonder on 07 Jun 2018
An important overview of the pros, cons and questions about My Health Record
7 June 2018 - After years of uncertainty about the future of a nationally effective eHealth system, Australia is now ...
Posted by Michael Wonder on 07 Jun 2018
The ICR responds to decision by NICE not to recommend abiraterone as first-line treatment for advanced prostate cancer
6 June 2018 - The Institute of Cancer Research, London, has expressed disappointment that the prostate cancer drug abiraterone (Zytiga) ...
Posted by Michael Wonder on 07 Jun 2018
Canada trails US in patient access to rare disease therapies, CORD President says
6 June 2018 - Canada’s healthcare system is excellent for people with common ailments like diabetes or high blood pressure, ...
Posted by Michael Wonder on 06 Jun 2018
Canada's drug shortage problem needs action, say medical experts
5 June 2018 - Drug shortages in Canada are a problem in need of immediate solutions, according to a new ...
Posted by Michael Wonder on 06 Jun 2018
Private health insurers already using Labor policy as a threat in negotiations
6 June 2018 - Health insurers are already using the threat of Labor's cap on annual premium rises to apply ...
Posted by Michael Wonder on 06 Jun 2018
Pharma giant Merck is planning for a Brexit supply blackout
6 June 2018 - Drug maker Merck may stockpile six months worth of goods. ...
Posted by Michael Wonder on 06 Jun 2018
NICE rejects Janssen’s Zytiga for early, aggressive prostate cancer
6 June 2018 - It is looking unlikely that Janssen’s Zytiga plus androgen deprivation therapy and prednisone/prednisolone will become routinely ...
Posted by Michael Wonder on 06 Jun 2018
Life-extending lung cancer drug will be more widely available on the NHS after NICE review
6 June 2018 - NICE says more people should be able to freely access pembrolizumab, known as Keytruda, after a new ...
Posted by Michael Wonder on 06 Jun 2018
PBS legislative amendments – 1 June 2018
6 June 2018 - Amendments to the National Health (Pharmaceutical Benefits) Regulations 2017 and the National Health (Subsection 84C(7)) Determination ...